To investigate the potential role of PAC in inhibiting the AKT/mTOR pathway in thyroid cancer cells, CAL-62 cells were either sham-treated or exposed to PAC (10 μM), and then were harvested at different periods of time (24, 48 and 72 h). This evidence concerns the gene MTOR and thyroid gland carcinoma.